Award Winners - Animal Health Nutrition Technology and Innovation

London, March 5th 2024 – EnsiliTech is proud to announce its recent successes at the annual Animal Health Nutrition Technology and Innovation Europe conference. The conference, a melting pot of scientific brilliance and industry expertise, provided an ideal platform for EnsiliTech to showcase its groundbreaking advancements surrounding animal vaccines and biologicals. Represented by our CEO, Asel Sartbaeva, and commercial director Dale Bullett, EnsiliTech ignited significant interest among the conference attendees.

During the Production Showcase session, Asel, together with eight representatives from other companies, took centre stage, each giving a 5-minute presentation. After giving a pitch, the judges questioned each of the speakers, probing theirs business models, as well as scientific rational of the technology and any future plans.

Asel’s presentation clearly resonated with the attendees, as the Audience Choice Award was bestowed upon EnsiliTech at the close of the event. Voted by conference attendees, this prestigious accolade reflects not only EnsiliTech’s technology promise, but also Asel’s ability to connect with the audience. Her passion for sustainable practices and her dedication to improving animal lives left a lasting impression.

Asel commented “I have thoroughly enjoyed the whole experience at the AHNTI, meeting new colleagues, building new connections, taking part in discussions and workshops, pitching and, of course, winning the pitch in the Production Showcase.”  

Asel Sartbaeva (left) receiving the award for Audience Choice award for Production Showcase.

 

EnsiliTech is a Bristol-based startup, which spun out from the University of Bath in July 2022. In January 2023, EnsiliTech had finalised a first, oversubscribed, pre-seed investment round of £1.2M. This consisted of an Innovate UK grant and private investment from Science Angels Syndicate, Fink Family Office, QantX, and angels.

If you’d like to find out more about our technology, or explore partnership opportunities, contact hello@ensilitech.com

Next
Next

SBRI Contract Awarded to Develop Novel Thermally Stable mRNA Hantaan Vaccine.